Differentiation of chronic mass-forming pancreatitis from pancreatic ductal adenocarcinoma using contrast-enhanced computed tomography

References

• Kleeff J, Korc M, Apte M, et al. Pancreatic cancer. Nat Rev Dis Primers. 2016;2:16022. doi:10.1038/nrdp.2016.2227158978
   PubMed Web of Science ®Google Scholar
• Conroy T, Van Laethem JL. Combination or single-agent chemotherapy as adjuvant treatment for pancreatic cancer? Lancet Oncol. 2019;20(3):336–337. doi:10.1016/S1470-2045(19)30310-930842047
   PubMed Web of Science ®Google Scholar
• Ren S, Chen X, Wang Z, et al. Differentiation of hypovascular pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinoma using contrast-enhanced computed tomography. PLoS One. 2019;14(2):e0211566. doi:10.1371/journal.pone.021156630707733
   PubMed Web of Science ®Google Scholar
• Gu X, Liu R. Application of 18f-FDG PET/CT combined with carbohydrate antigen 19-9 for differentiating pancreatic carcinoma from chronic mass-forming pancreatitis in Chinese elderly. Clin Interv Aging. 2016;11:1365–1370. doi:10.2147/CIA.S11525427729779
   PubMed Web of Science ®Google Scholar
• Weiss VL, Kiernan C, Wright J, et al. Fine-needle aspiration–based grading of pancreatic neuroendocrine neoplasms using Ki-67: is accurate WHO grading possible on cytologic material? J Am Soc Cytopathol. 2018;7(3):154–159. doi:10.1016/j.jasc.2018.02.00130038894
   PubMedGoogle Scholar
• Shi Y, Gao F, Li Y, et al. Differentiation of benign and malignant solid pancreatic masses using magnetic resonance elastography with spin-echo echo planar imaging and three-dimensional inversion reconstruction: a prospective study. Eur Radiol. 2018;28(3):936–945. doi:10.1007/s00330-017-5062-y28986646
   PubMed Web of Science ®Google Scholar
• Shi Y, Cang L, Zhang X, et al. The use of magnetic resonance elastography in differentiating autoimmune pancreatitis from pancreatic ductal adenocarcinoma: a preliminary study. Eur J Radiol. 2018;108:13–20. doi:10.1016/j.ejrad.2018.09.00130396645
   PubMed Web of Science ®Google Scholar
• Harmsen FR, Domagk D, Dietrich CF, Hocke M. Discriminating chronic pancreatitis from pancreatic cancer: contrast-enhanced EUS and multidetector computed tomography in direct comparison. Endosc Ultrasound. 2018;7(6):395–403. doi:10.4103/eus.eus_24_1830246709
   PubMed Web of Science ®Google Scholar
• Zhang TT, Wang L, Liu H, et al. Differentiation of pancreatic carcinoma and mass-forming focal pancreatitis: qualitative and quantitative assessment by dynamic contrast-enhanced MRI combined with diffusion-weighted imaging. Oncotarget. 2017;8(1):1744–1759. doi:10.18632/oncotarget.1212027661003
   PubMedGoogle Scholar
• Muhi A, Ichikawa T, Motosugi U, et al. Mass-forming autoimmune pancreatitis and pancreatic carcinoma: Differential diagnosis on the basis of computed tomography and magnetic resonance cholangiopancreatography, and diffusion-weighted imaging findings. J Magn Reson Imaging. 2012;35(4):827–836. doi:10.1002/jmri.2288122069025
   PubMed Web of Science ®Google Scholar
• Prignon A, Provost C, Alshoukr F, et al. Preclinical evaluation of Ga-DOTA-NT-20.3: a promising PET imaging probe to discriminate human pancreatic ductal adenocarcinoma from pancreatitis. Mol Pharm. 2019;16(6):2776–2784. doi:10.1021/acs.molpharmaceut.9b0028331013092
   PubMedGoogle Scholar
• Frøkjær JB, Akisik F, Farooq A, et al. Guidelines for the diagnostic cross sectional imaging and severity scoring of chronic pancreatitis. Pancreatology. 2018;18(7):764–773. doi:10.1016/j.pan.2018.06.00230177434
   PubMed Web of Science ®Google Scholar
• Yadav AK, Sharma R, Kandasamy D, et al. Perfusion CT–Can it resolve the pancreatic carcinoma versus mass forming chronic pancreatitis conundrum? Pancreatology. 2016;16(6):979–987. doi:10.1016/j.pan.2016.08.01127568845
   PubMed Web of Science ®Google Scholar
• Aslan S, Nural MS, Camlidag I, Danaci M. Efficacy of perfusion CT in differentiating of pancreatic ductal adenocarcinoma from mass-forming chronic pancreatitis and characterization of isoattenuating pancreatic lesions. Abdom Radiol. 2019;44(2):593–603. doi:10.1007/s00261-018-1776-9
   PubMed Web of Science ®Google Scholar
• Yin Q, Zou X, Zai X, et al. Pancreatic ductal adenocarcinoma and chronic mass-forming pancreatitis: differentiation with dual-energy MDCT in spectral imaging mode. Eur J Radiol. 2015;84(12):2470–2476. doi:10.1016/j.ejrad.2015.09.02326481480
   PubMed Web of Science ®Google Scholar
• Kim DW, Kim HJ, Kim KW, et al. Neuroendocrine neoplasms of the pancreas at dynamic enhanced CT: comparison between grade 3 neuroendocrine carcinoma and grade 1/2 neuroendocrine tumour. Eur Radiol. 2015;25(5):1375–1383. doi:10.1007/s00330-014-3532-z25465713
   PubMed Web of Science ®Google Scholar
• Ruan Z, Jiao J, Min D, et al. Multi-modality imaging features distinguish pancreatic carcinoma from mass-forming chronic pancreatitis of the pancreatic head. Oncol Lett. 2018;15(6):9735–9744.29805684
   PubMed Web of Science ®Google Scholar
• Guo C, Zhuge X, Wang Z, et al. Textural analysis on contrast-enhanced CT in pancreatic neuroendocrine neoplasms: association with WHO grade. Abdom Radiol. 2019;44(2):576–585. doi:10.1007/s00261-018-1763-1
   PubMed Web of Science ®Google Scholar
• Ahn SS, Kim MJ, Choi JY, et al. Indicative findings of pancreatic cancer in prediagnostic CT. Eur Radiol. 2009;19(10):2448–2455. doi:10.1007/s00330-009-1422-619415290
   PubMed Web of Science ®Google Scholar
• Dutta AK, Chacko A. Head mass in chronic pancreatitis: Inflammatory or malignant. World J Gastrointest Endosc. 2015;7(3):258–264. doi:10.4253/wjge.v7.i3.25825789097
   PubMedGoogle Scholar
• Tummala P, Rao S, Agarwal B. Differential diagnosis of focal non-cystic pancreatic lesions with and without proximal dilation of pancreatic duct noted on CT scan. Clin Transl Gastroenterol. 2013;4:e42. doi:10.1038/ctg.2013.1524195914
   PubMed Web of Science ®Google Scholar
• Choi SY, Kim SH, Kang TW, et al. Differentiating mass-forming autoimmune pancreatitis from pancreatic ductal adenocarcinoma on the basis of contrast-enhanced MRI and DWI findings. AJR Am J Roentgenol. 2016;206(2):291–300. doi:10.2214/AJR.15.1497426797355
   PubMed Web of Science ®Google Scholar
• Ren S, Chen X, Wang J, et al. Differentiation of duodenal gastrointestinal stromal tumors from hypervascular pancreatic neuroendocrine tumors in the pancreatic head using contrast-enhanced computed tomography. Abdom Radiol. 2019;44(3):867–876. doi:10.1007/s00261-018-1803-x
   PubMed Web of Science ®Google Scholar
• Takumi K, Fukukura Y, Higashi M, et al. Pancreatic neuroendocrine tumors: correlation between the contrast-enhanced computed tomography features and the pathological tumor grade. Eur J Radiol. 2015;84(8):1436–1443. doi:10.1016/j.ejrad.2015.05.00526022520
   PubMed Web of Science ®Google Scholar
• Jee KN. Mass forming chronic pancreatitis mimicking pancreatic cystic neoplasm: a case report. World J Gastroenterol. 2018;24(2):297–302. doi:10.3748/wjg.v24.i2.29729375215
   PubMed Web of Science ®Google Scholar